Overall Technical outlook

Price Summary

On 2026-03-02, Piramal Pharma Limited's stock started at 152.62, soared to 154.96, dropped to 150.91, and finished the day 0.12% higher at 152.81, with a trading volume of 2045585 shares.
During the past 52 weeks, the highest stock price was 230.11, and the lowest was 151.41.
According to 10 analysts, the future price is anticipated to vary between 195.0 and 310.0, with an average expected price of around 234.9.

Technicals

Support and Resistance: The price of 152.81 is supported at 153.69 and encounters resistance at 153.69. This suggests key levels where the price might find stability, with 153.69 providing a base and 153.69 acting as an upper boundary for PPLPHARMA.
PPLPHARMA supportResistance 43b8af
Support/Resistance for PPLPHARMA


Aroon: The Aroon indicator shows a continued bearish trend, with Aroon Down remaining at 100. This indicates strong downward momentum, but to understand the full implications, the trend should be examined alongside other technical indicators.
PPLPHARMA aroon 43b8af
Aroon chart for Piramal Pharma Limited


Bol. Bands: The price has fallen below the lower Bollinger Band and has remained there since the previous move, suggesting a strong bearish trend for PPLPHARMA. This sustained position below the band may indicate that the market is oversold, with downward pressure dominating the current trading environment. The persistent stay in this zone could signal further declines unless a reversal occurs, making it a key point for traders to watch closely.
PPLPHARMA bbands 43b8af
Bolinger Bands chart for Piramal Pharma Limited


Parabolic SAR: The PSAR for PPLPHARMA continues to signal a bearish stance, reinforcing a resistance level that could restrict upward movement. This resistance suggests that the market may remain under bearish pressure, with limited potential for breaking higher.
PPLPHARMA psar 43b8af
Parabolic Stop and Reverse chart for Piramal Pharma Limited


Stochastic: The Stochastic K-line has fallen below the D-line and remains under the 20 mark, indicating a mildly bearish signal. This suggests that the market may experience some downward pressure, but the overall bearish sentiment is not yet strong. Investors should be cautious, watching for further developments that could confirm this trend.
PPLPHARMA stoch 43b8af
Stochastic chart for Piramal Pharma Limited


Tripple Moving Agerage: The Tripple MOVING AVG is currently neutral, offering no clear guidance on market direction. This suggests that the market may be in a state of pause, with no strong trend emerging.
PPLPHARMA trippleSMA 43b8af
Tripple SMA chart for Piramal Pharma Limited


A thorough analysis of a company involves looking beyond its stock price movements and trading patterns. You must also examine its fundamentals, which include profitability, growth prospects, and competitive advantages. Additionally, the industry in which the company operates provides important context, as factors like technological innovations, regulation, and market demand influence performance. By integrating this information with technical analysis, more accurate predictions about the company's future can be made.